251 related articles for article (PubMed ID: 11352367)
1. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
Bhattachary S; Powell JH
Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
[TBL] [Abstract][Full Text] [Related]
2. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
Curran HV; Verheyden SL
Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
[TBL] [Abstract][Full Text] [Related]
3. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
4. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
Parrott AC; Lasky J
Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
[TBL] [Abstract][Full Text] [Related]
5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
6. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
Gouzoulis-Mayfrank E; Daumann J; Tuchtenhagen F; Pelz S; Becker S; Kunert HJ; Fimm B; Sass H
J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
[TBL] [Abstract][Full Text] [Related]
7. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
[TBL] [Abstract][Full Text] [Related]
8. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
Hanson KL; Luciana M
Psychol Med; 2004 Feb; 34(2):229-46. PubMed ID: 14982129
[TBL] [Abstract][Full Text] [Related]
10. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
[TBL] [Abstract][Full Text] [Related]
11. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
12. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
[TBL] [Abstract][Full Text] [Related]
13. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
15. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
Hanson KL; Luciana M
J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
[TBL] [Abstract][Full Text] [Related]
17. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
Dafters RI; Hoshi R; Talbot AC
Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
[TBL] [Abstract][Full Text] [Related]
18. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Fox HC; Parrott AC; Turner JJ
J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
[TBL] [Abstract][Full Text] [Related]
19. The relative contributions of ecstasy and cannabis to cognitive impairment.
Croft RJ; Mackay AJ; Mills AT; Gruzelier JG
Psychopharmacology (Berl); 2001 Jan; 153(3):373-9. PubMed ID: 11271410
[TBL] [Abstract][Full Text] [Related]
20. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
Zakzanis KK; Campbell Z; Jovanovski D
Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
